Connor, Clark & Lunn Investment Management Ltd. Argenx Se Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $167,684 - $248,987	454 New	454 $223,000
Q4 2022 Feb 10, 2023	SELL	$342.17 - $402.31 $2.11 Million - $2.48 Million	-6,158 Reduced 35.52%	11,180 $4.24 Million
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $2.52 Million - $2.9 Million	7,329 Added 73.22%	17,338 $6.12 Million
Q2 2022 Aug 05, 2022	BUY	$269.58 - $378.88 $2.46 Million - $3.46 Million	9,143 Added 1055.77%	10,009 $3.79 Million
Q1 2022 May 12, 2022	SELL	$254.45 - $351.06 $78,879 - $108,828	-310 Reduced 26.36%	866 $273,000
Q4 2021 Feb 10, 2022	SELL	$272.01 - $353.03 $29,921 - $38,833	-110 Reduced 8.55%	1,176 $412,000
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $379,370 - $450,845	1,286 New	1,286 $388,000
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $572,825 - $724,331	-2,658 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $338,735 - $618,569	2,658 New	2,658 $599,000
Q4 2019 Feb 12, 2020	SELL	$106.59 - $164.21 $2.98 Million - $4.6 Million	-27,986 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$113.31 - $150.51 $2.13 Million - $2.83 Million	-18,809 Reduced 40.19%	27,986 $3.19 Million
Q2 2019 Aug 07, 2019	SELL	$115.0 - $141.58 $1.01 Million - $1.25 Million	-8,805 Reduced 15.84%	46,795 $6.63 Million
Q1 2019 May 08, 2019	SELL	$98.85 - $134.59 $175,458 - $238,897	-1,775 Reduced 3.09%	55,600 $6.94 Million
Q4 2018 Feb 12, 2019	SELL	$63.81 - $109.82 $1.04 Million - $1.78 Million	-16,225 Reduced 22.04%	57,375 $5.51 Million
Q2 2018 Aug 02, 2018	BUY	$74.84 - $100.16 $2.35 Million - $3.15 Million	31,450 Added 74.61%	73,600 $6.1 Million
Q1 2018 May 14, 2018	BUY	$56.95 - $85.19 $560,957 - $839,121	9,850 Added 30.5%	42,150 $3.39 Million
Q4 2017 Feb 09, 2018	BUY	$22.57 - $63.56 $729,011 - $2.05 Million	32,300	32,300 $2.04 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.66 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$778 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account